Want to join the conversation?
Leading medical devices manufacturer $VAR received CE Mark for its latest ProBeam proton therapy system. Proton therapy is used to treat wide range of cancerous tumors. $VAR's ProBeam system with Dynamic Peak scanning provides clinicians the ability to precisely deliver the dose to cancer while minimizing the exposure to healthy tissues.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.